Abstract 2250
Background
Induction chemotherapy (ICT) followed by bioradiotherapy (BRT) is a validated conservative approach for fit LA-HNSCC patients (pts). However, in pts unfit for cisplatin-based chemotherapy, this treatment strategy remains a challenge. Paclitaxel in combination with anti-EGFR therapy is active and well-tolerated in the recurrent/metastatic setting. This study aims to evaluate this regimen as ICT followed by BRT.
Methods
A retrospective single institution analysis (2010-2016) of LA-HNSCC pts unfit for cisplatin-based chemotherapy (≥70 years-old and/or significant comorbidity) was performed. Pts were treated with paclitaxel plus anti-EGFR monoclonal antibody up to 9 weeks followed by radical BRT (IMRT with concurrent anti-EGFR therapy). Overall survival (OS) and progression free survival (PFS) were estimated by Kaplan-Meier method.
Results
A total of 44 pts were evaluated: median age 72 years-old (50-83), male 42; tumor location, pts (%): larynx 14 (32), oropharynx 10 (23) (HPV+ 0), hypopharynx 9 (21), oral cavity 7 (16), cervical unknown primary 4 (9); 7thed TNM stage, pts (%): EIII 11 (25), EIVa 19 (43) and EIVb 14 (32). ECOG status 0/1/2: 1/38/5 pts. Response rate to ICT: 32 pts (73%); 5 complete responses (CR) and 27 partial responses (PR). During ICT 5 pts (11%) presented grade 3/4 adverse events, and 1 patient (2%) died due to febrile neutropenia. 37 pts (84%) continued with radical BRT: 20 pts (45%) achieved CR, and 6 of them recurred. Median follow-up: 13.5 (1-52) months. For the whole cohort, median OS and PFS were 15.6 (95% CI 4.7-26.6) and 10.4 (95% CI 7.0-13.7) months, respectively. For the 35 pts who completed ≥6 weeks of ICT, median OS and PFS were 22.2 (95% IC 7.2-37.2) and 15.6 (95% IC 8.4-22.9) months, respectively. Larynx pts showed better outcome in comparison with other locations: median OS not reached (NR) vs 10.7 (p = 0.003) and median PFS NR vs 0 (p = 0.001); 9 pts (64%) preserved a functioning larynx and were alive by the time of the analysis.
Conclusions
Paclitaxel plus anti-EGFR therapy was well-tolerated and might be an effective ICT regimen for LA-HNSCC pts unfit for cisplatin. In our cohort, larynx pts obtained the greatest benefit from this regimen.
Clinical trial identification
Legal entity responsible for the study
Institut Catala de Oncologia.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1159 - Molecular characterization and search for founding effects in Canarian families with Hereditary Breast and Ovarian Cancer Syndrome
Presenter: Elisenda Llabres Valenti
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3725 - Effect of the polymorphism rs2066844 of the NOD2 gene on colon cancer incidence in a high cardiovascular risk population. Modulation by gender
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
3708 - Effect of the polymorphisms rs1476413, rs1801131, rs4846052 and rs6541003 of the MTHFR gene on prostate cancer in a high cardiovascular risk population
Presenter: Judith Begona Ramirez Sabio
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5057 - Association of a genetic variant in cyclin-dependent kinase Inhibitor 2A gene with the increased risk of breast cancer
Presenter: Soodabeh Shahid Sales
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5970 - Investigating the role of HAT protein TIP60 in regulating functional dynamics of nuclear receptor PXR
Presenter: KARISHMA BAKSHI
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1360 - The role of downregulated SIRT3 expression in patients with hepatocellular carcinoma
Presenter: Hanhee Jo
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1634 - Prediction and Intervention of Colorectal Cancer Risk with Artificial Intelligent System
Presenter: Yang Ge
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
4921 - Measuring the Efficiency of Cancer Care in Europe
Presenter: Rikard Althin
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
1235 - Circulating cell-free DNA isolated from plasma of mesenteric veins predicts prognosis in stage II colorectal cancer patients
Presenter: Chih-Yung Yang
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract
5169 - _lonality of uterine carcinosarcoma as a factor of clinical prognosis.
Presenter: Natalia Levitskaya
Session: Poster display session: Basic science, Endocrine tumours, Gastrointestinal tumours - colorectal & non-colorectal, Head and neck cancer (excluding thyroid), Melanoma and other skin tumours, Neuroendocrine tumours, Thyroid cancer, Tumour biology & pathology
Resources:
Abstract